Cystic Fibrosis Transmembrane Regulator Protein Mutations: `Class' Opportunity for Novel Drug Innovation

Author： MacDonald Kelvin D.   McKenzie Karen R.   Zeitlin Pamela L.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.9, Iss.1, 2007-01, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners

By Gallati Sabina   Hess Simone   Galié-Wunder Dorothea   Berger-Menz Elisabeth   Böhlen Dominik  

Reproductive BioMedicine Online, Vol. 19, Iss. 5, 2009-11 ,pp. : 685-694

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis: Progress to Date

By Becq Frédéric  

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 241-259

Adis International

Access to resources Recommend Favorite

Cystic fibrosis transmembrane regulator (CFTR) modulators

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 471-474

Informa Healthcare

Access to resources Recommend Favorite

Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies

By Antoniu Sabina Antonela  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 423-425

Informa Healthcare

Access to resources Recommend Favorite

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B.   Machen T.E.   Widdicombe J.   Fischer H.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite